Unbound MEDLINE

An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma.

Abstract

OBJECTIVES
We measured the serum concentration of a panel of inflammatory cytokines and evaluated their association with circulating proangiogenic biomarkers and with outcome in patients with pancreatic ductal adenocarcinoma (PDAC).
METHODS
We collected serum samples from 36 patients with PDAC, 9 patients with chronic pancreatitis, and 22 healthy volunteers as a control. Inflammatory cytokines and proangiogenic biomarkers were measured using the multianalyte xMAP array and carcinoembryonic antigen (CEA) and carbohydrate 19-9 by immunoassay.
RESULTS
Patients with PDAC had higher circulating levels of interleukin 6 (IL-6) than those of patients with pancreatitis or healthy individuals and higher levels of IL-10 and tumor necrosis factor α (TNF-α) compared with those of healthy individuals. In patients with PDAC, circulating IL-6, TNF-α, IL-1β, and IL-10 correlated with serum concentrations of vascular endothelial growth factor and basic fibroblast growth factor; circulating IL-6, IL-1β, and TNF-α correlated with carbohydrate 19-9; and IL-8, IL-10, and TNF-α correlated with CEA levels. Circulating IL-8, TNF-α, and CEA; tumor stage; and lymph node metastases were associated with a poor outcome.
CONCLUSIONS
The results of this exploratory study indicate that inflammatory cytokines should be pursued as potential prognostic biomarkers as well as targets for therapy in larger studies in PDAC.

Links

  • Publisher Full Text
  • Authors

    Dima SO, Tanase C, Albulescu R, Herlea V, Chivu-Economescu M, Purnichescu-Purtan R, Dumitrascu T, Duda DG, Popescu I

    Institution

    Center of Digestive Disease and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania.

    Source

    Pancreas 41:7 2012 Oct pg 1001-7

    MeSH

    Adult
    Aged
    CA-19-9 Antigen
    Carcinoembryonic Antigen
    Carcinoma, Pancreatic Ductal
    Cytokines
    Female
    Fibroblast Growth Factor 2
    Humans
    Interleukin-10
    Interleukin-1beta
    Interleukin-6
    Macrophages
    Male
    Middle Aged
    Pancreatic Neoplasms
    Prognosis
    Tumor Markers, Biological
    Tumor Necrosis Factor-alpha
    Vascular Endothelial Growth Factor A

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22722257